biotech investing Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness
biotech investing Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
medical device investing Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit
artificial intelligence investing Seegnal's Investor Meet & Greet with Corporate CEO, Mr. Elad Bibi-Aviv
artificial intelligence investing Seegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project
SAGA Metals Reports More Significant Assays Including 109.1 m at 49.88% Fe2O3, 8.53% TiO2, 0.316% V2O5 at the Radar Critical Minerals Project